CRBN — Corbion NV Income Statement
0.000.00%
Last trade - 00:00
- €1.14bn
- €1.85bn
- €1.44bn
- 63
- 45
- 37
- 44
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 976 | 987 | 1,071 | 1,458 | 1,444 |
Cost of Revenue | |||||
Gross Profit | 272 | 276 | 269 | 326 | 374 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 915 | 882 | 989 | 1,347 | 1,327 |
Operating Profit | 61.3 | 104 | 82 | 111 | 117 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 44.7 | 87.7 | 86.5 | 116 | 85.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | 25.8 | 73.1 | 78.3 | 90 | 72.9 |
Net Income Before Extraordinary Items | |||||
Net Income | 25.8 | 73.1 | 78.3 | 90 | 72.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 25.8 | 73.1 | 78.3 | 90 | 72.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.59 | 1.16 | 1.76 | 1.45 | 1.44 |
Dividends per Share |